We are live on ! Find out more
IPAS

Ipass Inc Common Stock
IPAS

Delisted

IPAS was delisted on the 12th of February, 2019.

33 hedge funds and large institutions have $4.75M invested in Ipass Inc Common Stock in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

3% less funds holding

Funds holding: 3433 (-1)

27% less capital invested

Capital invested by funds: $6.49M → $4.75M (-$1.73M)

Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.76%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
6
Closed
5
Calls
Puts
Net Calls
Net Calls Change

IPAS Hedge Fund Activity: Q1 2018 in Review

33 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Ipass Inc Common Stock (IPAS) for Q1 2018, worth a combined $4.75M — down 27% from $6.49M a quarter earlier.

Fund positioning in IPAS was balanced in Q1 2018: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 6 trimmed.

The largest buyer was Eidelman Virant Capital, opening a new position worth an estimated $291K. The largest seller was Adirondack Research & Management, cutting an estimated $140K.

  • 33 institutional investors held Ipass Inc Common Stock (IPAS) as of Q1 2018, down from 34 in Q4 2017.
  • Funds reported $4.75M of Ipass Inc Common Stock stock for Q1 2018, down 27% quarter-over-quarter.
  • 5 funds opened new Ipass Inc Common Stock positions in Q1 2018 and 5 closed out, a net change of 0 holders.
  • The largest Ipass Inc Common Stock buyer in Q1 2018 was Eidelman Virant Capital, an estimated $291K added.
  • The largest Ipass Inc Common Stock seller in Q1 2018 was Adirondack Research & Management, an estimated $140K sold.

Based on aggregated 13F filings for Q1 2018.